πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 635 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7728144

Biphenyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. Β· Granted Tue Jun 01 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 27 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7728004

Crystalline form of a quinolinone-carboxamide compound

Theravance, Inc. Β· Granted Tue Jun 01 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 27 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7728006

Quinolinone-carboxamide compounds as 5-HT4 receptor agonists

Theravance, Inc. Β· Granted Tue Jun 01 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 27 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7723470

Glycopeptide derivatives and pharmaceutical compositions containing the same

Theravance, Inc. Β· Granted Tue May 25 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 20 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7713931

Cross-linked glycopeptide-cephalosporin antibiotics

Theravance, Inc. Β· Granted Tue May 11 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 06 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7700777

Crystalline forms of a biphenyl compound

Theravance, Inc. Β· Granted Tue Apr 20 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7700550

Glycopeptide phosphonate derivatives

Theravance, Inc. Β· Granted Tue Apr 20 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7691878

Heteroarylalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists

Theravance, Inc. Β· Granted Tue Apr 06 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7687519

Biphenyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. Β· Granted Tue Mar 30 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7687521

Dialkylphenyl compounds having beta2 adrenergic receptor agonist and muscarinic receptor a

Theravance, Inc. Β· Granted Tue Mar 30 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7683173

Biphenyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. Β· Granted Tue Mar 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7674908

Indazole-carboxamide compounds as 5-HT4 receptor agonists

Theravance, Inc. Β· Granted Tue Mar 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7671198

Process for preparing intermediates to 5-HT4 receptor agonist compounds

Theravance, Inc. Β· Granted Tue Mar 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7662815

Diaryl ether Ξ²2 adrenergic receptor agonists

Theravance, Inc. Β· Granted Tue Feb 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7659403

Biphenyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. Β· Granted Tue Feb 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7655621

Cross-linked glycopeptide-cephalosporin antibiotics

Theravance, Inc. Β· Granted Tue Feb 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7649080

Cross-linked glycopeptide-cephalosporin antibiotics

Theravance, Inc. Β· Granted Tue Jan 19 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7642355

Biphenyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. Β· Granted Tue Jan 05 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 31 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7638639

Substituted pyrrolidine and related compounds

Theravance, Inc. Β· Granted Tue Dec 29 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 24 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7632847

Biphenyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. Β· Granted Tue Dec 15 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 10 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7629336

Biphenyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. Β· Granted Tue Dec 08 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 03 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7622508

8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists

Theravance, Inc. Β· Granted Tue Nov 24 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7622587

Crystalline form of a benzimidazole-carboxamide medicinal compound

Theravance, Inc. Β· Granted Tue Nov 24 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7622467

Aryl aniline derivatives as Ξ²2 adrenergic receptor agonists

Theravance, Inc. Β· Granted Tue Nov 24 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted